Methylprednisolone acetate NDC 60219-1574

NDC codes

FDA NDC Directory

Product NDC (as listed)60219-1574Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60219-1574Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60219-1574-1	60219157401	1 VIAL, SINGLE-DOSE in 1 CARTON (60219-1574-1) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Apr 10, 2022
60219-1574-5	60219157405	25 VIAL, SINGLE-DOSE in 1 CARTON (60219-1574-5) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Apr 10, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methylprednisolone acetate
Generic name (nonproprietary): methylprednisolone acetate
Active ingredients: Methylprednisolone acetate — 80 mg/mL
Dosage form: Injection, Suspension
Route: Intra-articular, Intralesional, Intramuscular, Soft tissue
Labeler: Amneal Pharmaceuticals NY LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210043
Marketing start: Apr 10, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 60219-1574_15d5342a-3521-4c06-b5d9-4218e5a067f4SPL ID 15d5342a-3521-4c06-b5d9-4218e5a067f4SPL set ID 8ea42650-21cd-49e4-92c8-48f2eeaf95bcRxCUI 1743779, 1743855UNII 43502P7F0P
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

J1040 — Injection, methylprednisolone acetate, 80 mg

Billing unit: 80 mg. Units on the claim = dose given ÷ 80 mg.

J1040 applies to methylprednisolone acetate. Methylprednisolone sodium succinate (for IV use) has different codes.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N460219157401 followed by a unit qualifier and the quantity

Package 60219-1574-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 19, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE A. For Intramuscular Administration When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of methylprednisolone acetate injectable suspension is indicated as follows: Allergic States: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic Diseases: Bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis fungoides, pemphigus, severe e…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210043

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210043
Product	Strength	Form · route	Labeler	Product NDC
Methylprednisolone acetate	Methylprednisolone acetate 40 mg/mL	Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Intrasynovial, Soft tissue	A-S Medication Solutions	50090-5894
Methylprednisolone acetate	Methylprednisolone acetate 40 mg/mL	Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Intrasynovial, Soft tissue	Sportpharm LLC	85766-031
Methylprednisolone acetate	Methylprednisolone acetate 80 mg/mL	Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Soft tissue	A-S Medication Solutions	50090-6024
Methylprednisolone acetate	Methylprednisolone acetate 40 mg/mL	Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Intrasynovial, Soft tissue	Amneal Pharmaceuticals NY LLC	60219-1573
Methylprednisolone acetate	Methylprednisolone acetate 80 mg/mL	Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Soft tissue	Amneal Pharmaceuticals LLC	70121-1552
Methylprednisolone acetate	Methylprednisolone acetate 40 mg/mL	Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Intrasynovial, Soft tissue	Amneal Pharmaceuticals LLC	70121-1573
Methylprednisolone acetate	Methylprednisolone acetate 80 mg/mL	Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Soft tissue	Amneal Pharmaceuticals LLC	70121-1574